-
Apigenin (SKU N1828): Reliable HDAC Inhibitor for Cellular A
2026-08-04
This scenario-driven article explores how Apigenin (SKU N1828) from APExBIO addresses real-world challenges in cell viability, proliferation, and neurodegeneration research. By grounding recommendations in published data and practical workflow considerations, the article helps researchers optimize protocols, interpret results, and select reliable reagents for reproducible outcomes.
-
Direct NRF2 Activation by Kaempferol Mitigates Inflammatory
2026-08-03
This study demonstrates that kaempferol directly activates NRF2 in osteoclasts, attenuating inflammatory bone loss by disrupting KEAP1–NRF2 interactions and modulating the immune microenvironment. The findings establish NRF2 as a key therapeutic target for osteolytic disease intervention and validate the role of selective NRF2 inhibition in dissecting pathway specificity.
-
HPF: Precision Hydroxyphenyl Fluorescein for hROS Detection
2026-08-03
HPF (hydroxyphenyl fluorescein) delivers unmatched specificity for highly reactive oxygen species detection, enabling robust intracellular oxidative stress visualization in advanced cell biology and cancer research. This guide details actionable workflows, key innovations, and practical troubleshooting to elevate your fluorescence-based ROS assays.
-
KNUCKLES Coordinates Auxin and Cytokinin for Floral Meristem
2026-08-02
This study uncovers how the transcriptional repressor KNUCKLES (KNU) directs floral meristem termination in Arabidopsis by integrating hormonal signaling. By linking chromatin-level gene repression to dynamic auxin and cytokinin modulation, the research advances molecular understanding of floral determinacy and stem cell regulation.
-
NU6300 Blocks Gasdermin D Cleavage and Palmitoylation in Pyr
2026-08-01
The reference study identifies NU6300 as a covalent inhibitor of gasdermin D, specifically targeting cysteine-191 to block both cleavage and palmitoylation, crucial steps in pyroptosis execution. This work advances understanding of inflammasome-driven diseases and highlights new mechanisms for modulating inflammatory cell death.
-
Lithium-Driven Exosomal Wnt10a Secretion Enhances Osteogenes
2026-07-31
This study uncovers how lithium stimulates bone mesenchymal stem cells (BMSCs) to secrete exosomes enriched in Wnt10a, thereby activating Wnt/β-catenin signaling and promoting osteogenesis. The findings illuminate a Rab11a-mediated mechanism for exosomal trafficking and suggest new molecular avenues for bone regeneration therapies.
-
Fluorescein TSA Fluorescence System Kit: Deeper Mechanistic
2026-07-31
Explore how the Fluorescein TSA Fluorescence System Kit unlocks advanced fluorescence detection of low-abundance biomolecules. This article delivers a mechanistic deep dive and cross-disciplinary evidence, setting a new benchmark for sensitive assay design.
-
JSH-23: Precision NF-κB Inhibitor for Inflammation Research
2026-07-30
JSH-23 from APExBIO is a benchmark NF-κB inhibitor enabling precise, mechanism-targeted inflammation research and acute injury modeling. Its unique selectivity for p65 nuclear translocation offers workflow advantages and supports reproducible inhibition of pro-inflammatory cytokines in both cellular and animal systems.
-
Chrysin Sensitizes RCC to Sunitinib by Inducing Ferroptosis
2026-07-30
This study demonstrates that chrysin, a natural flavonoid, enhances the sensitivity of renal cell carcinoma (RCC) cells to sunitinib by inducing ferroptosis through the PI3K/Akt/GPX4 pathway. The findings offer a mechanistic rationale for combining chrysin with sunitinib as a strategy to overcome drug resistance in RCC, with practical implications for improving therapeutic outcomes.
-
Enhancing Apoptosis in Pancreatic Cancer via Caspase-8/c-FLI
2026-07-29
This study demonstrates that pharmacological targeting of the caspase-8/c-FLIPL heterodimer synergizes with MCL1 inhibition and death ligand stimulation to enhance apoptosis in pancreatic cancer cells. The findings suggest a promising combinatorial strategy for overcoming apoptosis resistance in solid tumors, with implications for future therapeutic development.
-
S-Adenosylhomocysteine: Precision Modulator for Neural Assay
2026-07-29
Explore S-Adenosylhomocysteine as a pivotal tool for dissecting neural methylation dynamics and feedback inhibition in advanced research. This article reveals the underappreciated strategic value of SAH in neural differentiation models, focusing on assay optimization and mechanistic clarity.
-
LNP Design and Delivery Route Shape mRNA Therapy in Pregnanc
2026-07-28
This study systematically dissects how lipid nanoparticle (LNP) structure and administration route affect mRNA delivery, efficacy, and safety during pregnancy. The findings offer precise mechanistic guidance for designing potent, minimally immunogenic LNPs for maternal therapies, with implications for improved translational applications in gene regulation and mRNA delivery.
-
Dutasteride: Dual 5-Alpha-Reductase Inhibitor in Prostate Re
2026-07-28
Dutasteride’s dual inhibition of 5-alpha-reductase enables precise androgen pathway modulation, driving reproducible outcomes in prostate cancer and BPH research. This guide provides workflow enhancements, troubleshooting strategies, and the latest cross-domain assay insights for maximizing experimental value with APExBIO’s Dutasteride.
-
Alpha-Ketoglutarate in Metabolic Reprogramming Research
2026-07-27
Alpha-ketoglutarate (α-KGA) empowers advanced metabolic and immune cell studies by bridging TCA flux with immune modulation. Recent breakthroughs reveal its pivotal role in tumor microenvironment assays and resistance mechanisms, making it indispensable for cutting-edge enzyme system studies.
-
Decitabine (5-Aza-2'-deoxycytidine): Protocols and Advances
2026-07-27
Decitabine is a precision epigenetic modulator, enabling translational breakthroughs in hematopoietic malignancy and solid tumor research by reactivating silenced genes. This article details advanced workflows, troubleshooting strategies, and practical data for maximizing the impact of Decitabine (5-Aza-2'-deoxycytidine) in cancer epigenetics.
450 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page